BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

930 related articles for article (PubMed ID: 15893297)

  • 1. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventrolateral periaqueductal gray lesion attenuates nociception but does not change anxiety-like indices or fear-induced antinociception in mice.
    Mendes-Gomes J; Amaral VC; Nunes-de-Souza RL
    Behav Brain Res; 2011 Jun; 219(2):248-53. PubMed ID: 21238499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like effects produced by bilateral lesion of the periaqueductal gray in mice: Influence of concurrent nociceptive stimulation.
    Mendes-Gomes J; Nunes-de-Souza RL
    Behav Brain Res; 2009 Nov; 203(2):180-7. PubMed ID: 19410607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosterone does not change open elevated plus maze-induced antinociception in mice.
    Mendes-Gomes J; Miguel TT; Amaral VC; Nunes-de-Souza RL
    Horm Behav; 2011 Sep; 60(4):408-13. PubMed ID: 21798262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience.
    Baptista D; Bussadori K; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Oct; 1294():29-37. PubMed ID: 19635465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2015 Oct; 292():547-54. PubMed ID: 26183651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open elevated plus maze-induced antinociception in rats: a non-opioid type of pain inhibition?
    Cornélio AM; Nunes-de-Souza RL
    Physiol Behav; 2009 Mar; 96(3):440-7. PubMed ID: 19059275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2006 Mar; 1076(1):42-8. PubMed ID: 16476419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray.
    De Luca-Vinhas MC; Macedo CE; Brandão ML
    Pain; 2006 Mar; 121(1-2):94-104. PubMed ID: 16472918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
    Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
    Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
    Kincheski GC; Carobrez AP
    Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
    Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
    Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
    Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
    Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
    Baptista D; Nunes-de-Souza RL; Canto-de-Souza A
    Behav Brain Res; 2012 Nov; 235(1):42-7. PubMed ID: 22800924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
    Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
    Albrechet-Souza L; Cristina de Carvalho M; Rodrigues Franci C; Brandão ML
    Horm Behav; 2007 Aug; 52(2):267-73. PubMed ID: 17553501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.